Neogen Chemicals Ltd

Neogen Chemicals announced that the Board of Directors of the Company at its meeting held on 17 May 2025, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Neogen Chemicals declined 85.76% to Rs 2.41 crore in the quarter ended March 2025 as against Rs 16.93 crore during the previous quarter ended March 2024. Sales rose 1.59% to Rs 202.82 crore in the quarter ended March 2025 as against Rs 199.65 crore during the previous quarter ended March 2024. For the full year,net profit declined 2.30% to Rs 34.83 crore in the year ended March 2025 as against Rs 35.65 crore during the previous year ended March 2024. Sales rose 12.58% to Rs 777.56 crore in the year ended March 2025 as against Rs 690.67 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales202.82199.65 2 777.56690.67 13 OPM %17.9417.93 -17.5315.93 - PBDT24.5228.33 -13 92.0375.64 22 PBT17.7622.47 -21 64.2452.77 22 NP2.4116.93 -86 34.8335.65 -2 Powered by Capital Market - Live

Neogen Chemicals will hold a meeting of the Board of Directors of the Company on 17 May 2025.Powered by Capital Market - Live

Neogen Chemicals reported that a major fire incidence took place affecting operations at its plant located at Dahej SEZ on 05 March 2025, at around 12:30 am IST. The cause of fire will be assessed in due course. Due to timely and proactive action by the supervisory staff, the fire was controlled from spreading to other plants in the vicinity and fortunately, there were no casualty and injury to life. Dahej plant is one of the four plants of Neogen Chemicals. This plant is engaged in the production of organic chemicals. There has been no impact on the plant of Neogen Ionics situated in the vicinity. Production / Operation of the said division is suspended temporarily until the survey by the Insurance Company is conducted. The Company has already intimated the Insurance Company about the incidence and requested them to depute the Surveyor. Insurance Survey is expected to be conducted in due course. Powered by Capital Market - Live

Revenue from operations jumped 22.49% YoY to Rs 201.43 crore during the quarte, boosted by volume growth in the base business and a healthly contribution from BuLi Chem.The battery chemicals arm (Neogen Ionics) has commenced lithium salt exports, contributing to the topline. Neogen Ionics is positioned for substantial growth from next financial year driven by new capacities. Proft before tax (PBT) surged 167.54% to Rs 15.25 crore in Q3 FY25 compared with Rs 5.70 crore in Q3 FY24. EBITDA jumped 71% to Rs 34.6 crore. Strong EBITDA growth was a result of increased plant utilization, operational efficiencies and lower employee costs. Operating leverage kicked in due to higher volume achieved on an optimized cost structure. Cost intensity in Neogen Ionics reduced during the quarter following the commencement of export sales. Margins remained strong at 17.2% despite weak pricing. Absolute EBITDA on per kilo basis remained stable. Haridas Kanani, chairman & managing director, Neogen Chemicals said: 'Our Q3 FY25 results demonstrate a robust recovery, with revenue up 22% and EBITDA up 71%. This growth is attributed to strong ramp-up in BuLi Chem and sustained growth in the base business volumes. Higher topline was achieved despite lower RM prices and resultant realizations acrossseveral product categories. New product launches and the pursuit of export opportunities drove the robust recovery. To mitigate the persistent slowdown in agrochemicals, we have strategically created additional end-use sectors such as semiconductors, flavors & fragrances and select industrial CSM opportunities Neogen Ionics is rapidly advancing its Lithium Salts and Electrolyte projects. A major ACC battery manufacturer has already started trial production plant in India, with several others preparing to do so within the next two years. This will drive their demand for local procurement of both Electrolyte and Lithium Salt. We are on schedule to commission our greenfield Battery Materials facility in the second half of FY26. This facility, using MUIS technology, is taking shape with majority of erection and engineering works now complete. The modular construction process is proceeding with equipment assembly and installation. Overall, we are confident of achieving FY26 revenue guidance of Rs 950-1,000 crore in the standalone business. Beyond FY26, the rapid scale up in Neogen Ionics will drive consolidated performance.' Neogen Chemicals is India's one of the leading manufacturers of bromine-based and Lithium-based specialty chemicals. Its products are used in pharmaceutical and agrochemical intermediates, engineering fluids, electronic chemicals, polymer additives, water treatment, construction chemicals, and aroma chemicals, flavours and fragrances, specialty polymers, chemicals and vapour absorption chillers ' original-equipment manufacturers and with new upcoming usage in lithium-ion battery materials for energy storage and electric vehicles (EV) application.Powered by Capital Market - Live

Net profit of Neogen Chemicals rose 844.34% to Rs 10.01 crore in the quarter ended December 2024 as against Rs 1.06 crore during the previous quarter ended December 2023. Sales rose 22.49% to Rs 201.43 crore in the quarter ended December 2024 as against Rs 164.44 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales201.43164.44 22 OPM %17.2012.34 - PBDT22.3511.44 95 PBT15.255.70 168 NP10.011.06 844 Powered by Capital Market - Live

Neogen Chemicals will hold a meeting of the Board of Directors of the Company on 1 February 2025.Powered by Capital Market - Live

Neogen Chemicals and its wholly owned subsidiary, Neogen Ionics have received credit ratings from CRISIL as under: Neogen Chemicals: Total Bank Loan Facilities Rated Rs. 680 crore Long Term Rating - CRISIL A / Stable (Reaffirmed) Short Term Rating - CRISIL A1 (Reaffirmed) Neogen Ionics: Total Bank Loan Facilities Rated Rs. 1150 crore Long Term Rating - CRISIL A-/Stable (Assigned)Powered by Capital Market - Live

Neogen Chemicals will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

Neogen Chemicals announced the resignation of Ketan Vyas as Chief Financial Officer of the company with effect from 11 September 2024. Powered by Capital Market - Live